- 9
- 0
- 约7.22万字
- 约 46页
- 2016-10-28 发布于河南
- 举报
* A post hoc analysis of data from the TNT study (see slide 9), which compared treatment with 10 and 80 mg/d of atorvastatin in patients with stable CHD, was performed to assess the predictive value of HDL-C levels in the 9770 subjects for whom HDL-C data were available. The primary end point was time to a first major cardiovascular event, defined as death from CHD, nonfatal non–procedure-related MI, resuscitation after cardiac arrest, or fatal or nonfatal stroke. The expected 5-year risk for major cardiovascular events was determined for each quintile of HDL-C level at 3 months of treatment.
原创力文档

文档评论(0)